Trump Announces 100% Tariff on Branded Drug Imports to Spur Domestic Production
President TRUMP has unveiled aggressive new trade measures targeting the pharmaceutical industry, imposing a 100% tariff on all imported branded or patented drugs. The policy, announced via Truth Social posts, aims to force drugmakers to relocate manufacturing to U.S. soil. Companies already constructing American facilities—even at early stages—will receive exemptions.
The MOVE accelerates Trump's broader push to reshore manufacturing jobs. Pharmaceutical giants like Eli Lilly and Johnson & Johnson have begun domestic investments, but the tariffs now create urgent financial incentives for holdouts. A parallel 25% tariff on heavy truck imports signals this protectionist strategy extends beyond healthcare.